Technical Analysis for AHROQ - Atheronova Inc

Grade Last Price % Change Price Change
grade C 0.003 0.00% 0.0000
AHROQ closed unchanged on Wednesday, August 21, 2019, on 0 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical AHROQ trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 0.00%

Older signals for AHROQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
AtheroNova Inc. is a clinical-stage biopharmaceutical company. The Company through its subsidiary, AtheroNova Operations, Inc., is focused on the research and development of compounds to regress atherosclerotic plaque and improve lipid profiles in humans. The Company develops various applications for its compounds to be used for the treatment of atherosclerosis. The Company's development products include AHRO-001 and AHRO-002. The Company's pipeline candidates include applications for the treatment of localized reduction of subcutaneous fat deposits through transdermal application, obesity, hypertension, diabetes and Peripheral Artery Disease (PAD). The Company's lead compound is AHRO-001. Through the process of reverse cholesterol transport, the compound is designed to dissolve plaque within the walls of the arteries and removes it from the body through natural metabolic processes. AHRO-001 and AHRO-002 are orally administered compounds.
RTT Biopharmaceutical Diabetes Nutrition Hypertension Obesity Circulatory System Angiology Aging Associated Diseases Vascular Diseases Atheroma Atherosclerosis Cholesterol Peripheral Artery Disease Cardiovascular System Various Applications
Is AHROQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0583
52 Week Low 0.0006
Average Volume 32,404
200-Day Moving Average 0.0055
50-Day Moving Average 0.0026
20-Day Moving Average 0.0029
10-Day Moving Average 0.0036
Average True Range 0.001
ADX 18.91
+DI 46.2025
-DI 25.3165
Chandelier Exit (Long, 3 ATRs ) 0.0035
Chandelier Exit (Short, 3 ATRs ) 0.0041
Upper Bollinger Band 0.0053
Lower Bollinger Band 0.0005
Percent B (%b) 0.52
BandWidth 165.517241
MACD Line 0.0004
MACD Signal Line 0.0003
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0030
Resistance 3 (R3) 0.0030 0.0030 0.0030
Resistance 2 (R2) 0.0030 0.0030 0.0030 0.0030
Resistance 1 (R1) 0.0030 0.0030 0.0030 0.0030 0.0030
Pivot Point 0.0030 0.0030 0.0030 0.0030 0.0030
Support 1 (S1) 0.0030 0.0030 0.0030 0.0030 0.0030
Support 2 (S2) 0.0030 0.0030 0.0030 0.0030
Support 3 (S3) 0.0030 0.0030 0.0030
Support 4 (S4) 0.0030